CogState Limited (ASX: CGS) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
CogState Limited Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
CogState Limited (ASX: CGS)
Latest News
⏸️ Investing
2 biotech picks that could provide big returns for growth investors
⏸️ Investing
6 top shares I'd buy this April
⏸️ Investing
Why I rate CogState Ltd shares a speculative buy
⏸️ Investing
Why the CogState Limited share price dipped 5% on today's results
⏸️ Investing
4 monster shares in the making
⏸️ Investing
Cogstate Limited posts more strong growth
⏸️ Investing
Why these 4 ASX shares have sunk lower today
⏸️ Investing
Why the CogState Limited share price fell 7% today
⏸️ Investing
Why the CogState Limited share price rocketed a massive 27% today
⏸️ Investing
5 stocks that have tripled in the last 12 months
⏸️ Investing
Here's why the shares of CogState Limited rocketed 22% today
⏸️ Investing
6 ASX tech stocks for your watchlist in 2016
Frequently Asked Questions
-
No, Cogstate does not pay dividends at this stage.
-
Cogstate Ltd listed on the ASX on 13 February 2004.
CGS ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About CogState Limited
Cogstate Ltd (ASX: CGS) is a neuroscience technology company specialising in brain health assessments. The principal activity of the company is the sale of technology and services to measure cognition.
The company provides licensed digital tests for health professionals and medical researchers. Its services include scientific consultancy, project management, data management, statistical analysis, and reporting. Cogstate generates the bulk of its revenue from its clinical trials segment.
Cogstate's technology has been used in more than 2,000 scientific and clinical trial studies. These include fields such as Alzheimer's, depression, and bipolar disorder research as well as studies investigating cognitive impairment in athletes as a result of concussive injuries.
